Chitosan-Based Gels for the Drug Delivery System - Chitosan Based Hydrogels: Functions and Applications - page 303

45. Shantha, K. L., Bala, U., and Rao, K. P. 1995. Tailor-made chitosans for drug delivery. Eur Polym J
31: 377-382.
46. Kweon, D. K. and Kang, D. W. 1999. Drug-release behavior of chitosan-g-poly(vinyl alcohol)
copolymer matrix. J Appl Polym Sci 74: 458-464.
47. Tang, J., Hua, D. B., Cheng, J. X., Jiang, J., and Zhu, X. L. 2008. Synthesis and properties of
temperature-responsive chitosan by controlled free radical polymerization with chitosan-RAFT
agent. Int. J. Biol. Macromol. 43: 383-389.
48. Hennink, W. E., De Jong, S. J., Bos, G. W., Veldhuis, T. F. J., and van Nostrum, C. F. 2004.
Biodegradable dextran hydrogels cross-linked by stereocomplex formation for the controlled
release of pharmaceutical proteins. Int J Pharm 277: 99-104.
49. Shu, X. Z. and Zhu, K. J. 2002. Controlled drug release properties of ionically cross-linked chi-
tosan beads: The influence of anion structure. Int J Pharm 233: 217-225.
50. Anal, A. K., Stevens, W. F., and Remuñán-López, C. 2006. Ionotropic cross-linked chitosan
microspheres for controlled release of ampicillin. Int. J. Pharm. 312: 166-173.
51. Yao, K. D., Yao, F. L., Li, J. J., and Yin, Y. J. 2008. Chitosan-based gels. In Smart Materilas , M. S.
Schwartz, ed. 10-2-10-13. Boca Raton, FL: Taylor& Francis.
52. Yin, Y., Li, Z., Sun, Y., and Yao, K. 2005. A preliminary study on chitosan/gelatin polyelectrolyte
complex formation. J Mater Sci 40: 4649-4652.
53. Chenite, A., Chaput, C., Wang, D., Combes, C., Buschmann, M. D., Hoemann, C. D., Leroux, J. C.,
Atkinson, B. L., Binette, F., and Selmani, A. 2000. Novel injectable neutral solutions of chitosan
form biodegradable gel in situ. Biomaterials 21: 2155-2161.
54. Chenite, A., Buschmann, M., Wang, D., Chaputa, C., and Kandanic, N. 2001. Rheological charac-
terization of thermogelling chitosan/glycerolphosphate solutions. Carbohydr Polym 46: 39-47.
55. Jarry, C. and Shive, M. S. Chitosan-based hydrogels in biomedical and pharmaceutical sciences.
In Smart Materilas , M. S. Schwartz, ed. 10-13-10-20. Boca Raton, FL: Taylor & Francis.
56. Philippova, O. E., Volkov, E. V., Sitnikova, N. L., Khokhlov, A. R., Desbrieres, J., and Rinaudo,
M. 2001. Two types of hydrophobic aggregates in aqueous solutions of chitosan and its hydro-
phobic derivative. Biomacromolecules 2: 483-490.
57. Nguyen, M. K. and Lee, D. S. 2010. Injectable biodegradable hydrogels. Macromol Biosci 10:
563-579.
58. Tang, Y. F., Du, Y., M., Hu, X. W., Shi, X. W., and Kennedy, J. F. 2007. Rheological characterisation of
a novel thermosensitive chitosan/oly(vinyl alcohol) blend hydrogel. Carbohydr Polym 67: 491-499.
59. Xiao, C. M., Gao, F., and Gao, Y. K. 2010. Controlled preparation of physically cross-linked
chitosan-g-poly(vinyl alcohol) hydrogel. J Appl Polym Sci 117: 2946-2950.
60. Koyano, T., Koshizaki, N., Umehara, H., Naguru, M., and Minoura, N. 2000. Surface states of
PVA/chitosan blended hydrogels. Polymer 41: 4461-4465.
61. Tang, Y. F. and Du, Y. M. 2008. Chitosan-based injectable and thermosensitive hydrogel. Prog
Chem 20: 239-244.
62. Muzzarelli, R. A. A. 2009. Genipin-cross-linked chitosan hydrogels as biomedical and pharma-
ceutical aids. Carbohydr Polym 77: 1-9.
63. Marguerite, R. 2010. New way to cross-link chitosan in aqueous solution. Eur Polym J 46:
1537-1544.
64. Weng, L., Romanov, A., Rooney, J., and Chen, W. 2008. Non-cytotoxic, in situ gelable hydrogels
composed of N -carboxyethyl chitosan and oxidized dextran. Biomaterial 29: 3905-3913.
65. Simi, C. K. and Abraham, T. E. 2010. Transparent xyloglucan-chitosan complex hydrogels for
different applications. Food Hydrocolloids 24: 72-80.
66. Hiemstra, C., van der Aa, L. J., Zhong, Z. Y., Dijkstra, P. J., and Feijen, J. 2007. Rapidly in situ -
forming degradable hydrogels from dextran thiols through Michael addition. Biomacromolecules
8: 1548-1556.
67. Van de Wetering, P., Metters, A. T., Schoenmakers, R. G., and Hubbell, J. A. 2005. Poly(ethylene
glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and
release of pharmaceutically active proteins. J Control Release 102: 619-627.